ARTICLE | Company News
Biovista, Novartis deal
May 2, 2011 7:00 AM UTC
Biovista will use its Clinical Outcome Search Space (COSS) technology to identify new indications for undisclosed Novartis compounds. Biovista will receive an upfront payment and is eligible for miles...